Lipid metabolism as a driver of therapy resistance in triple negative breast cancer

[News]

Lipid metabolism has emerged as a central player in the progression and therapy resistance of breast cancer, particularly the aggressive subtype known as triple-negative breast cancer (TNBC).

More... (https://www.news-medical.net/news/20250420/Lipid-metabolism-as-a-driver-of-therapy-resistance-in-triple-negative-breast-cancer.aspx)